Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA.
J Subst Abuse Treat. 2014 Feb;46(2):106-12. doi: 10.1016/j.jsat.2013.08.016. Epub 2013 Oct 4.
This study examined the relationship between substance treatment referrals and depression improvement among 2,373 participants with concurrent substance use and depressive disorders enrolled in an integrated behavioral health program. Three groups of substance treatment referral status were identified: accessed treatment (n=780), declined treatment (n=315), and no referral for treatment (n=1278). The primary outcome is improvement in depressive symptoms (PHQ-9<10 or ≥50% reduction). Using propensity score adjustments, patients accessing substance treatment were significantly more likely to achieve depression improvement than those who declined receiving treatment services (hazard ratio (HR)=1.82, 95% confidence interval (CI): 1.50-2.20, p<0.001) and those without a referral for treatment (HR=1.13, 95% CI: 1.03-1.25, p=0.014). Each 1 week delay in initiating a referral was associated with a decreased likelihood of depression improvement (HR=0.97, 95% CI: 0.96-0.98, p<0.001). Study findings highlight the need of enhancing early treatment contact for co-occurring substance use disorders in primary care.
本研究考察了在参加综合性行为健康计划的同时患有物质使用障碍和抑郁障碍的 2373 名参与者中,物质治疗转介与抑郁改善之间的关系。确定了三组物质治疗转介状态:接受治疗(n=780)、拒绝治疗(n=315)和未转介治疗(n=1278)。主要结局是抑郁症状的改善(PHQ-9<10 或≥50%减少)。通过倾向评分调整,接受物质治疗的患者比拒绝接受治疗服务的患者(危险比(HR)=1.82,95%置信区间(CI):1.50-2.20,p<0.001)和未转介治疗的患者(HR=1.13,95%CI:1.03-1.25,p=0.014)更有可能改善抑郁症状。每延迟一周开始转介与抑郁改善的可能性降低相关(HR=0.97,95%CI:0.96-0.98,p<0.001)。研究结果强调了在初级保健中加强对共病物质使用障碍的早期治疗接触的必要性。